Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Carbon dots derived from Pollen Typhae (PT-CDs) improved BUN, CRE, urine volume, kidney index, and histopathological morphology in RM-induced AKI rats [PMID:36814298]
Aqueous and methanolic pollen extracts showed dose-dependent inhibition of carrageenan-induced paw edema and granuloma formation in rats [PMID:23248413]; rhizome flour prevented intestinal inflammation in a rat colitis model [PMID:22559191]
Pollen decoction is used clinically in China; specific pectin polysaccharides (PTPS-2-2) inhibited lipid accumulation in vitro in L02 cells [PMID:36657842]; typhactyloside is used in Pushen capsules for clinical treatment [PMID:39840606]
Isorhamnetin-3-O-neohesperidin and typhaneoside were identified as the main anti-nociceptive constituents of the pollen [PMID:30580603]
Synthèse des preuves
Sources PubMed
- 1.PMID: 31270392 (2019) — Species-Specific Biodegradation of Sporopollenin-Based Microcapsules. · Scientific reports
- 2.PMID: 36814298 (2023) — Ultrasmall and highly biocompatible carbon dots derived from natural plant with amelioration against acute kidney injury. · Journal of nanobiotechnology
- 3.PMID: 31787383 (2020) — Selenite antagonizes the phytotoxicity of Cd in the cattail Typha angustifolia. · Ecotoxicology and environmental safety
- 4.PMID: 39458804 (2024) — Pharmacological Potential and Electrochemical Characteristics of Typha angustifolia Pollen. · Plants (Basel, Switzerland)
- 5.PMID: 36043710 (2022) — Isorhamnetin: A Novel Natural Product Beneficial for Cardiovascular Disease.